Related Experiment Video
Updated: Aug 21, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
MDM2 expression in EBV-infected nasopharyngeal carcinoma cells
Han-Chung Wu1, Tung-Ying Lu, Jeng-Jie Lee
1Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract:
To understand whether the p53-regulated mdm2 gene expression was altered by the Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC), the NPC-TW01 cell line was infected by EBV through IgA receptor-mediated endocytosis. The mdm2 gene was expressed only in a small fraction of the NPC cell population and could be enhanced in the EBV-infected (EBV+) cells. In the animals bearing EBV+ and EBV- NPC xenografts, the MDM2+ cells only appeared in clusters in both EBV+ and EBV- tumors with stronger expression in EBV+ cells. Cotransfection of pmdm2-Luc plus pSV40-p53 plus pCMV-LMP1 in the NPC-TW06 line that had p53 heterozygous point mutation showed stronger mdm2 promoter activity than cells cotransfected with pmdm2-Luc plus pSV40-p53, but no mdm2 promoter activity was seen in cells cotransfected with pmdm2-Luc plus pCMV-LMP1. Only the EBV-LMP1 but not the EBV-LMP2A gene could enhance p53 to upregulated mdm2 expression. Tumor cells in NPC biopsy specimens revealed similar mdm2 expression as in the animal model. It is concluded that although EBV can indirectly enhance mdm2 gene expression in tumor cells that express this gene, it cannot turn on or directly regulate mdm2 expression in cells that do not express this gene. In other words, EBV plays a role as an enhancer in NPC tumorigenesis.
Insights
Epstein-Barr virus (EBV) enhances mdm2 gene expression in nasopharyngeal carcinoma (NPC) cells already expressing it, acting as an enhancer in NPC tumorigenesis. It does not directly regulate or initiate mdm2 expression in non-expressing cells.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Nasopharyngeal carcinoma (NPC) is a malignancy influenced by Epstein-Barr virus (EBV).
- The MDM2 gene is a key regulator of the p53 tumor suppressor, and its expression is critical in tumorigenesis.
- Understanding the interplay between EBV and MDM2 in NPC is crucial for elucidating cancer development.
Purpose of the Study:
- To investigate whether Epstein-Barr virus (EBV) alters the expression of the p53-regulated MDM2 gene in nasopharyngeal carcinoma (NPC).
- To determine the role of EBV infection in the regulation of MDM2 expression within NPC cells and tumors.
Main Methods:
- Infection of NPC-TW01 cell line with EBV via IgA receptor-mediated endocytosis.
- Analysis of mdm2 gene expression in EBV-infected (EBV+) and EBV-negative (EBV-) NPC cells and xenografts.
- Reporter gene assays (pmdm2-Luc) to assess mdm2 promoter activity following cotransfection with p53 and EBV-LMP genes (LMP1, LMP2A).
- Examination of mdm2 expression in NPC biopsy specimens.
Main Results:
- MDM2 gene expression was observed in a subset of NPC cells and was enhanced in EBV+ cells.
- MDM2+ cells appeared in clusters in both EBV+ and EBV- xenografts, with stronger expression in EBV+ tumors.
- EBV-LMP1, but not EBV-LMP2A, enhanced p53-mediated upregulation of mdm2 expression, indicated by increased mdm2 promoter activity.
- Tumor cells in NPC biopsies showed similar mdm2 expression patterns as observed in the animal models.
Conclusions:
- EBV indirectly enhances mdm2 gene expression in NPC tumor cells that already express it.
- EBV does not initiate or directly regulate mdm2 expression in cells that do not inherently express the gene.
- EBV functions as an enhancer, contributing to NPC tumorigenesis through modulation of existing mdm2 expression pathways.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
